| Value | ₹3.52 Cr |
|---|
BSE filing, BSE: 543943. Summary written from the filing by ALFA Finder's alert engine.
Asarfi Hospital Ltd: key numbers
- Share price
- ₹166.95
- Market cap
- ₹328.5 Cr
- Revenue (annual)
- ₹173.5 Cr
- Net profit (annual)
- ₹16.66 Cr
- P/E (TTM)
- 19.7×Sector 34.1×
- Promoter holding
- 61.18%+0.01% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Asarfi Hospital Ltd
All →Asarfi Hospital Other Announcement
Asarfi Hospital Ltd has filed its shareholding pattern for the quarter ended September 30, 2026. This disclosure outlines the current distribution of equity shares.
Asarfi Hospital Credit Rating
Asarfi Hospital Ltd announced that CRISIL Ratings upgraded its bank facilities credit rating. The total rated bank facilities are now ₹60 Crore, enhanced from ₹46.5 Crore.
- Value
- ₹60.00 Cr
Asarfi Hospital Annual General Meeting
Asarfi Hospital Ltd's 21st Annual General Meeting held on September 18, 2026, saw shareholder approval for financial statements, director reappointment, and migration to the BSE Main Board.
Asarfi Hospital Annual Report
Asarfi Hospital Limited has submitted its Annual Report for the Financial Year 2025-26 in compliance with SEBI Listing Regulations.
Asarfi Hospital Other Announcement
Asarfi Hospital Limited has appointed M/s Ashutosh Kumar Sinha & Co as the Cost Auditor for the financial year 2026-27, as approved by the Board.
Asarfi Hospital Board Meeting Outcome
Asarfi Hospital approved its 21st AGM, appointment of auditors, and migration from BSE SME to the BSE Main Board and NSE.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.